NanoVibronix, Inc. (NASDAQ:NAOV) Sees Significant Decline in Short Interest

NanoVibronix, Inc. (NASDAQ:NAOV) saw a large drop in short interest in February. As of February 15th, there was short interest totalling 95,700 shares, a drop of 94.2% from the January 31st total of 1,660,000 shares. Based on an average daily trading volume, of 3,450,000 shares, the short-interest ratio is presently 0.0 days. Approximately 1.1% of the shares of the stock are short sold.

NanoVibronix Price Performance

NASDAQ:NAOV opened at $0.35 on Friday. The company has a market capitalization of $3.05 million, a price-to-earnings ratio of -0.28 and a beta of 1.63. The business has a 50 day moving average of $0.49 and a 200 day moving average of $0.57. NanoVibronix has a 1-year low of $0.31 and a 1-year high of $1.27.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.